CDK4/6-IN-9

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

CDK4/6-IN-9 

CDK4/6-IN-9 (compound 10) 是一种选择性 CDK4/6 抑制剂，对 CDK6/cyclin D1 的 IC50 为 905 nM。CDK4/6-IN-9 具有用于多发性骨髓瘤 (MM) 研究的潜力。

CDK4/6-IN-9

CDK4/6-IN-9 Chemical Structure

CAS No. : 2688098-02-2

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

CDK4/6-IN-9 (compound 10) is a selective CDK4/6 inhibitor with an IC50 of 905 nM for CDK6/cyclin D1. CDK4/6-IN-9 has the potential for multiple myeloma (MM) research[1].

IC50 & Target[1]

CDK6/cyclinD1

905 nM (IC50)

CDK4/cyclinD1

 

分子量

418.47

Formula

C22H23FN8
CAS 号

2688098-02-2
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Kai Yuan, et al. Discovery of novel and orally bioavailable CDK 4/6 inhibitors with high kinome selectivity, low toxicity and long-acting stability for the treatment of multiple myeloma. Eur J Med Chem. 2022 Jan 15;228:114024.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务